159 results on '"Bramson J"'
Search Results
2. High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome
3. Obstacles to effective Toll-like receptor agonist therapy for hematologic malignancies
4. Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines
5. Non-toxic cross-reactivity with healthy tissues supports in vivo expansion and therapeutic efficacy of T cells engineered with synthetic antigen receptors
6. Actinide bioassays by ICPMS
7. Development of a CD19-TAC therapy in preparation of human trials
8. Optimizing the culture process of engineered t cells to favor long-term efficacy following adoptive immunotherapy
9. BCMA-specific TAC receptor-engineered T cells for multiple myeloma
10. New neuronal lineage tumor antigen and therapeutic targeting thereof
11. T cells engineered with T-cell antigen coupler (TAC) receptors display robust efficacy against solid and liquid tumor xenografts in the absence of any toxicity
12. 391 - New neuronal lineage tumor antigen and therapeutic targeting thereof
13. 301 - Optimizing the culture process of engineered t cells to favor long-term efficacy following adoptive immunotherapy
14. 4 - T cells engineered with T-cell antigen coupler (TAC) receptors display robust efficacy against solid and liquid tumor xenografts in the absence of any toxicity
15. 6 - BCMA-specific TAC receptor-engineered T cells for multiple myeloma
16. Critical assessment of automated flow cytometry data analysis techniques
17. T helper cell IL-4 drives intestinal Th2 priming to oral peanut antigen, under the control of OX40L and independent of innate-like lymphocytes
18. Bifurcations and Chaotic Dynamics in a Tumour-Immune-Virus System.
19. High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome
20. Semliki Forest virus and Kunjin virus RNA replicons elicit comparable cellular immunity but distinct humoral immunity
21. Combination Therapy with Interleukin-2 and Wild-Type p53 Expressed by Adenoviral Vectors Potentiates Tumor Regression in a Murine Model of Breast Cancer
22. IL-12 gene therapy protects mice in lethal Klebsiella pneumonia.
23. Construction of a Double Recombinant Adenovirus Vector Expressing a Heterodimeric Cytokine:In VitroandIn VivoProduction of Biologically Active Interleukin-12
24. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance
25. Increased DNA Synthesis and Repair-Enzyme Expression in Lymphocytes From Patients With Chronic Lymphocytic Leukemia Resistant to Nitrogen Mustards
26. State initiatives to integrate the Medicare and Medicaid programs for dually eligible beneficiaries.
27. Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors.
28. Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination.
29. Lack of evidence for a high-affinity sarcosinamide carrier or a catecholamine carrier in Calu-1 lung-cancer cells, HT-29 colon-cancer cells, and DHF fibroblasts.
30. Direct Intratumoral Injection of an Adenovirus Expressing Interleukin-12 Induces Regression and Long-Lasting Immunity That Is Associated with Highly Localized Expression of Interleukin-12
31. Combination Therapy with Interleukin-2 and Wild-Type p53 Expressed by Adenoviral Vectors Potentiates Tumor Regression in a Murine Model of Breast Cancer
32. Critical assessment of automated flow cytometry data analysis techniques
33. Immunotherapy of murine breast cancer using an adenovirus vector expressing interleukin-12
34. Nitrogen mustard resistant chronic lymphocytic leukemia as a model for in-vivo resistance to cross-linking agents
35. Defining the critical hurdles in cancer immunotherapy
36. The use of adenoviral vectors for gene therapy and gene transfer in vivo
37. DNA repair enzyme expression in chronic lymphocytic leukemia vis-a-vis nitrogen mustard drug resistance
38. Potentiation of chlorambucil toxicity in B-CLL lymphocytes using the DNA synthesis inhibitors aphidicolin and 1- -D-arabinofuranosylcytosine
39. Effect of alkyl-N-purine DNA glycosylase overexpression on cellular resistance to bifunctional alkylating agents
40. Pyroptosis activates conventional type I dendritic cells to mediate the priming of highly functional anticancer T cells.
41. Immunomodulatory drugs have divergent effects on humoral and cellular immune responses to SARS-CoV-2 vaccination in people living with rheumatoid arthritis.
42. Protocol for a longitudinal cohort study of Lyme disease with physical, mental and immunological assessment.
43. Impact of Simultaneous Circulating Tumor DNA and Tissue Genotyping in the Workup of Stage IV Lung Adenocarcinoma on Quality of Care in an Academic Community Medical Center.
44. Abstracts of the Cell Therapy Transplant Canada 2022 Annual Conference.
45. The histologic effects of neoadjuvant stereotactic body radiation therapy (SBRT) followed by pulmonary metastasectomy-rationale and protocol design for the Post SBRT Pulmonary Metastasectomy (PSPM) trial.
46. Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections.
47. Peanut allergen reaction thresholds during controlled food challenges in 2 Canadian randomized studies (Canada-ARM1 and PISCES).
48. The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma.
49. Trends in Hospice Quality Oversight and Key Challenges to Making it More Effective, 2006-2015.
50. Adverse Effects of Immune Checkpoint Inhibitors (Programmed Death-1 Inhibitors and Cytotoxic T-Lymphocyte-Associated Protein-4 Inhibitors): Results of a Retrospective Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.